Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Millions of SEK in funding for malaria research at Umeå University

06.09.2005


The molecular biologist Cathrine Persson at Umeå University has been allotted SEK 2.5 million from the U.S. National Institutes of Health (NIH) for research on a vaccine against malaria.

The project “Immunogenicity of synthetic peptide malaria vaccines” spans five years and is designed to study the protection offered by various synthetic vaccines against malaria. Cathrine Persson is collaborating with Professor Elizabeth Nardin, NYU School of Medicine in New York.

The funding is being provided by the National Institute of Allergy and Infectious Diseases (NIAID), one of the 27 institutes and centers that make up the NIH, a federal body that both pursues and provides support for various types of medical research in the U.S. and abroad. The competition for this funding is extremely stiff, and it is not often that scientists in Sweden are selected for grants. The application submitted by Cathrine and her associate was given high scores in the assessment process. Malaria is a major world health problem, and there is no vaccine at present.



“It’s our hope that we will be able to come up with an effective vaccine. This would be a tremendous breakthrough in efforts to develop protection against malaria,” says Cathrine Persson.

Malaria claims several millions of human lives every year and is caused by a group of single-cell parasites (so-called protzoas) that are transmitted to humans by mosquitoes. People who live in malaria-infested areas develop antibodies against the Circumsporozoite protein (CS), a protein on the surface of the malaria parasite. Owing to the ability of CS to stimulate our immune defense, it is included in several trial vaccines that have been tested on humans. A major problem with all vaccine trials is that there is no good way to measure to what extent an individual has developed protection against malaria after being vaccinated. By constructing hybrid parasites that contain parts of the CS protein, Cathrine Persson’s research aims to show what parts of CS are best at stimulating our immune defense. The hybrid parasites will moreover be used as a tool to analyze the outcome of vaccination trials.

Hans Fällman | alfa
Further information:
http://www.molbiol.umu.se/forskning/CathrinePersson
http://www.umu.se

More articles from Health and Medicine:

nachricht Biofilm discovery suggests new way to prevent dangerous infections
23.05.2017 | University of Texas at Austin

nachricht Another reason to exercise: Burning bone fat -- a key to better bone health
19.05.2017 | University of North Carolina Health Care

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Turmoil in sluggish electrons’ existence

An international team of physicists has monitored the scattering behaviour of electrons in a non-conducting material in real-time. Their insights could be beneficial for radiotherapy.

We can refer to electrons in non-conducting materials as ‘sluggish’. Typically, they remain fixed in a location, deep inside an atomic composite. It is hence...

Im Focus: Wafer-thin Magnetic Materials Developed for Future Quantum Technologies

Two-dimensional magnetic structures are regarded as a promising material for new types of data storage, since the magnetic properties of individual molecular building blocks can be investigated and modified. For the first time, researchers have now produced a wafer-thin ferrimagnet, in which molecules with different magnetic centers arrange themselves on a gold surface to form a checkerboard pattern. Scientists at the Swiss Nanoscience Institute at the University of Basel and the Paul Scherrer Institute published their findings in the journal Nature Communications.

Ferrimagnets are composed of two centers which are magnetized at different strengths and point in opposing directions. Two-dimensional, quasi-flat ferrimagnets...

Im Focus: World's thinnest hologram paves path to new 3-D world

Nano-hologram paves way for integration of 3-D holography into everyday electronics

An Australian-Chinese research team has created the world's thinnest hologram, paving the way towards the integration of 3D holography into everyday...

Im Focus: Using graphene to create quantum bits

In the race to produce a quantum computer, a number of projects are seeking a way to create quantum bits -- or qubits -- that are stable, meaning they are not much affected by changes in their environment. This normally needs highly nonlinear non-dissipative elements capable of functioning at very low temperatures.

In pursuit of this goal, researchers at EPFL's Laboratory of Photonics and Quantum Measurements LPQM (STI/SB), have investigated a nonlinear graphene-based...

Im Focus: Bacteria harness the lotus effect to protect themselves

Biofilms: Researchers find the causes of water-repelling properties

Dental plaque and the viscous brown slime in drainpipes are two familiar examples of bacterial biofilms. Removing such bacterial depositions from surfaces is...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

AWK Aachen Machine Tool Colloquium 2017: Internet of Production for Agile Enterprises

23.05.2017 | Event News

Dortmund MST Conference presents Individualized Healthcare Solutions with micro and nanotechnology

22.05.2017 | Event News

Innovation 4.0: Shaping a humane fourth industrial revolution

17.05.2017 | Event News

 
Latest News

Scientists propose synestia, a new type of planetary object

23.05.2017 | Physics and Astronomy

Zap! Graphene is bad news for bacteria

23.05.2017 | Life Sciences

Medical gamma-ray camera is now palm-sized

23.05.2017 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>